11:09 AM EDT, 03/28/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.49% to 1,404.43 on the S&P Europe Select ADR Index, which is about 1.5% lower for the week.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which advanced 49% and 5.2% respectively. They were followed by pharmaceutical company Sanofi ( SNY ) , which rose 1.5%.

The decliners from continental Europe were led by internet advertising firm Criteo ( CRTO ) , which fell 3.6%. It was followed by internet browser company Opera (OPRA) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which were down 3.1% and 2.8% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana ( NCNA ) and utilities provider National Grid ( NGG ) , which increased 5.6% and 2.9% respectively. They were followed by telecommunications operator Vodafone Group ( VOD ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which were up 2% and 1.6% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biopharmaceutical company Amarin ( AMRN ) , which lost 3.1% and 2.9% respectively. They were followed by financial services company Barclays ( JJCTF ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which dropped 2.7% and 2.1% respectively.